Equatorial Guinea vs Russian Federation: Tuberculosis treatment success rate
Equatorial Guinea
68.0%
in 2023
Russian Federation
68.0%
in 2023
Equatorial Guinea rank
166th
Russian Federation rank
166th
Tuberculosis treatment success rate over time
- Equatorial Guinea
- Russian Federation
How they compare
Equatorial Guinea currently reports 68.0% against 68.0% in Russian Federation, a difference of 0.0%.
The two have swapped places 9 times across 19 shared years of data; in 1995 it was Equatorial Guinea ahead.
Equatorial Guinea ranks 166th and Russian Federation ranks 166th of 206 countries.
Across the 4 decades both report, Equatorial Guinea averaged higher in 2 and Russian Federation in 2.
Head to head by decade
| Decade | Equatorial Guinea | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 82.7% | 63.0% | 19.7% | Equatorial Guinea |
| 2000s | 57.0% | 66.8% | 9.8% | Russian Federation |
| 2010s | 67.0% | 69.0% | 2.0% | Russian Federation |
| 2020s | 70.8% | 64.2% | 6.5% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Equatorial Guinea or Russian Federation?
- Equatorial Guinea, at 68.0% against 68.0% in Russian Federation as of 2023.
- What is the difference in tuberculosis treatment success rate between Equatorial Guinea and Russian Federation?
- 0.0%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Russian Federation?
- 19 years are reported by both, from 1995 to 2023.
- How do Equatorial Guinea and Russian Federation rank globally for tuberculosis treatment success rate?
- Equatorial Guinea ranks 166th and Russian Federation ranks 166th of 206 countries.
- Where does this data come from?
- WHO (2025) β with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.